2025 – Spring Partner Engagement Meeting held on 29th April
Resource Category Archives
Pharmaceutical and Medical Device Carbon Footprinting Standard
The founding project of the coalition was to develop a greenhouse gas (GHG) accounting guidance document for the pharmaceutical and medical device sector. This research was initiated from the GHG appraisal of the NHS that identified pharmaceuticals and medical devices contributing over 25% to the total NHS carbon footprint. The purpose of this guidance is Continue reading “Pharmaceutical and Medical Device Carbon Footprinting Standard”
A Perspective on Environmental Sustainability Assessments in the Healthcare Sector
A discussion paper titled “Challenges and recommendations for environmental sustainability assessments of pharmaceutical products in the healthcare sector” has been published in Green Chemistry by Wouter De Soete of Ghent University, Johnson & Johnson, GlaxoSmithKline, the Sustainable Healthcare Coalition and the American Chemical Society. Healthcare represents a significant portion of the global economy so, it Continue reading “A Perspective on Environmental Sustainability Assessments in the Healthcare Sector”
A Manifesto for Global Sustainable Health
A manifesto has been produced that attempts to summarise the thoughts explored by the Sustainable Health Symposium that was held in Cambridge in July, 2017 and sponsored by the Sustainable Healthcare Coalition. Across the globe, the health of individuals, their communities and the planet is in crisis as key drivers including rising inequity, food insecurity, Continue reading “A Manifesto for Global Sustainable Health”
Healthcare, Circular Economy Principles and Sustainable Wellbeing
Global expenditure on healthcare represented close to 10% of GDP in 2015, a proportion that is anticipated to grow because of increasing access to healthcare, as a consequence of an ageing global population and the higher demands placed on healthcare services as we age. At the same time, the provision of healthcare plays a part Continue reading “Healthcare, Circular Economy Principles and Sustainable Wellbeing”
Balancing Sustainability and Access: The Future of Off-Patent Medicines
The off-patent medicines industry is a cornerstone of European healthcare, accounting for 70% of medicines dispensed in Europe. These drugs treat a range of severe conditions, including cancer, respiratory diseases, and autoimmune disorders, forming an essential part of health systems. However, the significant economic and health impact of the off-patent medicines industry comes with great Continue reading “Balancing Sustainability and Access: The Future of Off-Patent Medicines”
Sustainable Clinical Trials by Design
July 2026 | A structured, repeatable approach to measuring the carbon footprint of clinical trials
Minimising waste in clinical trials
July 2026 | Protocol-level decisions have the greatest leverage on the volume of consumables, samples, and packaging a trial goes on to generate.
Minimise patient & staff travel in clinical trials
July 2026 | Every visit a trial requires is also a journey with a carbon cost. Redesigning where and how those journeys happen is one of the most direct levers a trial has for decarbonising.
Quantifying the carbon footprint of clinical trials: guidance development and case studies
BMJ | Jan 2024 “The urgency of the climate crisis requires attention from biomedical research, not least clinical trials which can involve significant greenhouse gas emissions.”
